| 0 |
Polyene Antimicrobial [EPC] |
7 |
0.0171 |
| 1 |
Quinolone Antimicrobial [EPC] |
37 |
0.0037 |
| 2 |
Lipid-based Polyene Antifungal [EPC] |
17 |
0.0013 |
| 3 |
Plasma Volume Expander [EPC] |
3 |
0.0010 |
| 4 |
Anticholinergic [EPC] |
12 |
0.0007 |
| 5 |
Aminoglycoside Antibacterial [EPC] |
25 |
0.0006 |
| 6 |
Polyene Antifungal [EPC] |
17 |
0.0004 |
| 7 |
Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
7 |
0.0003 |
| 8 |
Cholinergic Muscarinic Antagonist [EPC] |
10 |
0.0003 |
| 9 |
Azole Antifungal [EPC] |
39 |
0.0002 |
| 10 |
Antiseptic [EPC] |
1 |
0.0002 |
| 11 |
alpha-1 Adrenergic Agonist [EPC] |
1 |
0.0002 |
| 12 |
Tetracycline-class Drug [EPC] |
15 |
0.0002 |
| 13 |
Vitamin D3 Analog [EPC] |
4 |
0.0002 |
| 14 |
Fluoroquinolone Antibacterial [EPC] |
22 |
0.0002 |
| 15 |
Glycopeptide Antibacterial [EPC] |
11 |
0.0002 |
| 16 |
Erythropoiesis-stimulating Agent [EPC] |
5 |
0.0001 |
| 17 |
Insulin [EPC] |
4 |
0.0001 |
| 18 |
Corticosteroid [EPC] |
107 |
0.0001 |
| 19 |
Nucleoside Analog Antiviral [EPC] |
7 |
0.0001 |
| 20 |
Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
9 |
0.0001 |
| 21 |
Macrolide Antimicrobial [EPC] |
4 |
0.0001 |
| 22 |
Interleukin-31 Receptor alpha Antagonist [EPC] |
1 |
0.0001 |
| 23 |
Dihydrofolate Reductase Inhibitor Antibacterial [EPC] |
6 |
0.0001 |
| 24 |
Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
7 |
0.0001 |
| 25 |
Human Immunoglobulin G [EPC] |
1 |
0.0000 |
| 26 |
Prostaglandin Analog [EPC] |
4 |
0.0000 |
| 27 |
Purine Antimetabolite [EPC] |
4 |
0.0000 |
| 28 |
Non-Standardized Chemical Allergen [EPC] |
3 |
0.0000 |
| 29 |
Calcineurin Inhibitor Immunosuppressant [EPC] |
5 |
0.0000 |
| 30 |
Alkylating Drug [EPC] |
9 |
0.0000 |
| 31 |
Aminosalicylate [EPC] |
3 |
0.0000 |
| 32 |
Antirheumatic Agent [EPC] |
3 |
0.0000 |
| 33 |
Aromatase Inhibitor [EPC] |
3 |
0.0000 |
| 34 |
Folate Analog Metabolic Inhibitor [EPC] |
11 |
0.0000 |
| 35 |
RANK Ligand Inhibitor [EPC] |
5 |
0.0000 |
| 36 |
CD20-directed Cytolytic Antibody [EPC] |
7 |
0.0000 |
| 37 |
Vascular Endothelial Growth Factor Inhibitor [EPC] |
4 |
0.0000 |
| 38 |
Selective T Cell Costimulation Modulator [EPC] |
3 |
0.0000 |
| 39 |
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
1 |
0.0000 |
| 40 |
Acetylcholine Release Inhibitor [EPC] |
2 |
0.0000 |
| 41 |
Janus Kinase Inhibitor [EPC] |
3 |
0.0000 |
| 42 |
Osmotic Laxative [EPC] |
5 |
0.0000 |
| 43 |
Loop Diuretic [EPC] |
7 |
0.0000 |
| 44 |
Nitroimidazole Antimicrobial [EPC] |
1 |
0.0000 |
| 45 |
Insulin Analog [EPC] |
6 |
0.0000 |
| 46 |
Dihydropyridine Calcium Channel Blocker [EPC] |
4 |
0.0000 |
| 47 |
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
1 |
0.0000 |
| 48 |
Interleukin-6 Receptor Antagonist [EPC] |
1 |
0.0000 |
| 49 |
Vitamin D [EPC] |
2 |
0.0000 |
| 50 |
Vitamin B12 [EPC] |
2 |
0.0000 |
| 51 |
Vitamin C [EPC] |
2 |
0.0000 |
| 52 |
Nonsteroidal Anti-inflammatory Drug [EPC] |
3 |
0.0000 |
| 53 |
GLP-1 Receptor Agonist [EPC] |
1 |
0.0000 |
| 54 |
Interleukin-4 Receptor alpha Antagonist [EPC] |
1 |
0.0000 |
| 55 |
Thalidomide Analog [EPC] |
1 |
0.0000 |
| 56 |
Kinase Inhibitor [EPC] |
1 |
0.0000 |